Telomir Pharmaceuticals Files 8-K Report
Ticker: TELO · Form: 8-K · Filed: Jun 5, 2025 · CIK: 1971532
Sentiment: neutral
Topics: 8-K, other-events, filing
TL;DR
Telomir Pharma (TLO) filed an 8-K for 'Other Events' on June 5th. Watch for details.
AI Summary
On June 5, 2025, Telomir Pharmaceuticals, Inc. filed an 8-K report. The filing indicates an 'Other Events' item, suggesting a significant development not covered by other standard 8-K categories. The company is incorporated in Florida and its principal executive offices are located in Miami.
Why It Matters
This 8-K filing signals a material event for Telomir Pharmaceuticals, Inc., requiring disclosure to investors and the market.
Risk Assessment
Risk Level: medium — An 8-K filing for 'Other Events' can indicate a wide range of significant, but not yet categorized, corporate actions or developments.
Key Numbers
- 001-41952 — SEC File Number (Identifies the company's filing with the SEC.)
- 87-2606031 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Telomir Pharmaceuticals, Inc. (company) — Registrant
- June 5, 2025 (date) — Date of earliest event reported
- Florida (location) — State of Incorporation
- Miami (location) — Address of Principal Executive Offices
- 786-396-6723 (phone_number) — Registrant's telephone number
FAQ
What specific event triggered the 'Other Events' filing for Telomir Pharmaceuticals, Inc. on June 5, 2025?
The provided text does not specify the exact event, only that it falls under the 'Other Events' category of an 8-K filing.
What is the primary business of Telomir Pharmaceuticals, Inc. according to the filing?
The filing lists the Standard Industrial Classification as 'PHARMACEUTICAL PREPARATIONS [2834]'.
Where are Telomir Pharmaceuticals, Inc.'s principal executive offices located?
The principal executive offices are located at 100 SE 2nd St, Suite 2000, #1009, Miami, Florida.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated June 5, 2025.
What is the SEC file number for Telomir Pharmaceuticals, Inc.?
The SEC file number for Telomir Pharmaceuticals, Inc. is 001-41952.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 5, 2025 regarding Telomir Pharmaceuticals, Inc. (TELO).